RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
REGENTIS BIOMATERIALS LTD.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026
$1.48−0.01 (-0.67%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$1.47 (+14,700%)past year
Weekly closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$13.65M
- EPS, diluted
- -$24.16
Four years at a glance
Fiscal years 2022 to 2025, USD
Operating income
-$6.97M-847.6% YoY
Net income
-$13.65M-384.3% YoY
EPS, diluted
-$24.16-1504.7% YoY
Reported period